Dr Rob Commons

PhD student

Qualifications:

Fellow of the Royal Australasian College of Physicians (FRACP), Royal Australasian College of Physicians, 2013; Masters of Public Health and Tropical Medicine (MPH&TM), James Cook University, 2015; Diploma of Obstetrics and Gynaecology, Royal Australia and New Zealand College of Obstetrics and Gynaecology, 2008; Bachelor of Medicine, Bachelor of Surgery, University of Melbourne, 2006; Bachelor of Medical Science, University of Melbourne, 2006

Research Topic:

Primaquine radical cure of Plasmodium vivax malaria: a risk-benefit analysis

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Rob Commons is an infectious diseases and general medicine physician who is currently undertaking a PhD supervised by Professor Ric Price at the Global Health and Tropical Medicine Division of Menzies School of Health Research in Darwin into a risk-benefit analysis of the use of primaquine as radical cure for Plasmodium vivax malaria.

Rob developed an interest in research while completing a Bachelor of Medical Science research year during his undergraduate medical training, investigating the relationship between group A streptococcal superantigens and disease. After graduating, he continued to mix research with clinical practice. Work on multidrug resistant tuberculosis in Papua New Guinea with the Burnet Institute, combined with study for a Masters of Public Health degree and research into the increasing morbidity associated with diabetic foot infections in Northern Australia focused his interests towards global health. 

  • Primaquine radical cure of Plasmodium vivax malaria: a risk-benefit analysis 
  1. Commons, R., Robinson, C., Davis, J., Gawler, D., & Price, R. (2015). High Burden of Diabetic Foot Infections in the Top End of Australia: An Emerging Health Crisis (DEFINE Study). Diabetes Research and Clinical Practice.
  2. Commons, R., Smeesters, P., Proft, T., Fraser, J.D., Robins-Browne, R., & Curtis, N. (2014). A framework for streptococcal superantigen nomenclature and disease association. Trends in Molecular Medicine, 20(1), 48-62.
  3. Commons, R., McBryde, E., Valcanis, M., Powling, J., Street, A., & Hogg, G. (2012). Twenty-six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistance. Medical Journal of Australia, 196(5), 332-6.
  4. Commons, R., Rogers, S., Gooding, T., Danchin, M., Carapetis, J., Robins-Browne, R., & Curtis, N. (2008). Superantigen genes in group A streptococcal isolates and their relationship with emm types. Journal of Medical Microbiology, 57(pt 10),1238-46.
  5. Commons, R., Grivas, R., & Currie, B. (2014). Melioidosis in a patient on biologic agents for psoriatic arthritis. Internal Medical Journal, 44(12a), 1245-6.
  6. Commons, R., & Denholm, J. (2012).Triaging pandemic flu: pneumonia severity scores are not the answer. International Journal of Tuberculosis and Lung Disease, 16(5), 670-3.
  7. Commons, R., Dimitriou, J., & Campbell, I. (2008). Acalculous cholecystitis caused by Salmonella Virchow. ANZ Journal of Surgery, 78(6), 514.
  8. Rogers, S., Commons, R., Danchin, M., Selvaraj, G., Kelpie, L., Curtis, N., Robins-Browne, R., & Carapetis, J. (2007). Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Journal of Infectious Diseases, 195, 1625-33.
  9. Miller, H.M., Tong, A., Tunnicliffe, D.J., Campbell, D., Pinter, J., Commons, R.J., et al. (2016). Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units. Hemodialysis International, Jul 8 doi: 10.1111/hdi.12457
  1. 2016 NHMRC Research Excellence Awards

    2016 NHMRC Research Excellence Awards

    Date

    Two inspiring health researchers from Menzies School of Health Research (Menzies) were awarded prestigious National Health and Medical Research Council (NHMRC) Research Excellence Awards last night in Canberra.